0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Meloxicam Drug Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-15O7086
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Meloxicam Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Meloxicam Drug Market Research Report 2025

Code: QYRE-Auto-15O7086
Report
August 2025
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Meloxicam Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Meloxicam Drug Market

Meloxicam Drug Market

The global market for Meloxicam Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Meloxicam (Mobic) is used to treat pain or inflammation caused by osteoarthritis or rheumatoid arthritis. 
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Meloxicam Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meloxicam Drug.
The Meloxicam Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Meloxicam Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meloxicam Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Meloxicam Drug Market Report

Report Metric Details
Report Name Meloxicam Drug Market
CAGR 5%
Segment by Type
  • Tablet
  • Capsule
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer-Ingelheim, TerSera Therapeutics, Iroko Pharmaceuticals, Apotex, Yung Shin Pharmaceutical, Breckenridge Pharmaceutical, Zydus Pharmaceuticals, Unichem Pharmaceuticals, Strides Pharma, Cipla, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Teva, PuraCap Pharmaceutical, TARO, Lupin Pharmaceuticals, Aurobindo Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Meloxicam Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Meloxicam Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Meloxicam Drug Market report?

Ans: The main players in the Meloxicam Drug Market are Boehringer-Ingelheim, TerSera Therapeutics, Iroko Pharmaceuticals, Apotex, Yung Shin Pharmaceutical, Breckenridge Pharmaceutical, Zydus Pharmaceuticals, Unichem Pharmaceuticals, Strides Pharma, Cipla, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Teva, PuraCap Pharmaceutical, TARO, Lupin Pharmaceuticals, Aurobindo Pharma

What are the Application segmentation covered in the Meloxicam Drug Market report?

Ans: The Applications covered in the Meloxicam Drug Market report are Osteoarthritis in Adults (OA), Rheumatoid Arthritis in Adults (RA), Pediatric Patients

What are the Type segmentation covered in the Meloxicam Drug Market report?

Ans: The Types covered in the Meloxicam Drug Market report are Tablet, Capsule

Recommended Reports

Pain Management Drugs

Musculoskeletal Disorders

Pharmaceutical Ingredients

1 Meloxicam Drug Market Overview
1.1 Product Definition
1.2 Meloxicam Drug by Type
1.2.1 Global Meloxicam Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablet
1.2.3 Capsule
1.3 Meloxicam Drug by Application
1.3.1 Global Meloxicam Drug Market Value by Application (2024 VS 2031)
1.3.2 Osteoarthritis in Adults (OA)
1.3.3 Rheumatoid Arthritis in Adults (RA)
1.3.4 Pediatric Patients
1.4 Global Meloxicam Drug Market Size Estimates and Forecasts
1.4.1 Global Meloxicam Drug Revenue 2020-2031
1.4.2 Global Meloxicam Drug Sales 2020-2031
1.4.3 Global Meloxicam Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Meloxicam Drug Market Competition by Manufacturers
2.1 Global Meloxicam Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Meloxicam Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Meloxicam Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Meloxicam Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Meloxicam Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Meloxicam Drug, Product Type & Application
2.7 Global Key Manufacturers of Meloxicam Drug, Date of Enter into This Industry
2.8 Global Meloxicam Drug Market Competitive Situation and Trends
2.8.1 Global Meloxicam Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Meloxicam Drug Players Market Share by Revenue
2.8.3 Global Meloxicam Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Meloxicam Drug Market Scenario by Region
3.1 Global Meloxicam Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Meloxicam Drug Sales by Region: 2020-2031
3.2.1 Global Meloxicam Drug Sales by Region: 2020-2025
3.2.2 Global Meloxicam Drug Sales by Region: 2026-2031
3.3 Global Meloxicam Drug Revenue by Region: 2020-2031
3.3.1 Global Meloxicam Drug Revenue by Region: 2020-2025
3.3.2 Global Meloxicam Drug Revenue by Region: 2026-2031
3.4 North America Meloxicam Drug Market Facts & Figures by Country
3.4.1 North America Meloxicam Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Meloxicam Drug Sales by Country (2020-2031)
3.4.3 North America Meloxicam Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Meloxicam Drug Market Facts & Figures by Country
3.5.1 Europe Meloxicam Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Meloxicam Drug Sales by Country (2020-2031)
3.5.3 Europe Meloxicam Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meloxicam Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Meloxicam Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Meloxicam Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Meloxicam Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Meloxicam Drug Market Facts & Figures by Country
3.7.1 Latin America Meloxicam Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Meloxicam Drug Sales by Country (2020-2031)
3.7.3 Latin America Meloxicam Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Meloxicam Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Meloxicam Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Meloxicam Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Meloxicam Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Meloxicam Drug Sales by Type (2020-2031)
4.1.1 Global Meloxicam Drug Sales by Type (2020-2025)
4.1.2 Global Meloxicam Drug Sales by Type (2026-2031)
4.1.3 Global Meloxicam Drug Sales Market Share by Type (2020-2031)
4.2 Global Meloxicam Drug Revenue by Type (2020-2031)
4.2.1 Global Meloxicam Drug Revenue by Type (2020-2025)
4.2.2 Global Meloxicam Drug Revenue by Type (2026-2031)
4.2.3 Global Meloxicam Drug Revenue Market Share by Type (2020-2031)
4.3 Global Meloxicam Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Meloxicam Drug Sales by Application (2020-2031)
5.1.1 Global Meloxicam Drug Sales by Application (2020-2025)
5.1.2 Global Meloxicam Drug Sales by Application (2026-2031)
5.1.3 Global Meloxicam Drug Sales Market Share by Application (2020-2031)
5.2 Global Meloxicam Drug Revenue by Application (2020-2031)
5.2.1 Global Meloxicam Drug Revenue by Application (2020-2025)
5.2.2 Global Meloxicam Drug Revenue by Application (2026-2031)
5.2.3 Global Meloxicam Drug Revenue Market Share by Application (2020-2031)
5.3 Global Meloxicam Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boehringer-Ingelheim
6.1.1 Boehringer-Ingelheim Company Information
6.1.2 Boehringer-Ingelheim Description and Business Overview
6.1.3 Boehringer-Ingelheim Meloxicam Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boehringer-Ingelheim Meloxicam Drug Product Portfolio
6.1.5 Boehringer-Ingelheim Recent Developments/Updates
6.2 TerSera Therapeutics
6.2.1 TerSera Therapeutics Company Information
6.2.2 TerSera Therapeutics Description and Business Overview
6.2.3 TerSera Therapeutics Meloxicam Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 TerSera Therapeutics Meloxicam Drug Product Portfolio
6.2.5 TerSera Therapeutics Recent Developments/Updates
6.3 Iroko Pharmaceuticals
6.3.1 Iroko Pharmaceuticals Company Information
6.3.2 Iroko Pharmaceuticals Description and Business Overview
6.3.3 Iroko Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Iroko Pharmaceuticals Meloxicam Drug Product Portfolio
6.3.5 Iroko Pharmaceuticals Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Company Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Meloxicam Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Apotex Meloxicam Drug Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Yung Shin Pharmaceutical
6.5.1 Yung Shin Pharmaceutical Company Information
6.5.2 Yung Shin Pharmaceutical Description and Business Overview
6.5.3 Yung Shin Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Yung Shin Pharmaceutical Meloxicam Drug Product Portfolio
6.5.5 Yung Shin Pharmaceutical Recent Developments/Updates
6.6 Breckenridge Pharmaceutical
6.6.1 Breckenridge Pharmaceutical Company Information
6.6.2 Breckenridge Pharmaceutical Description and Business Overview
6.6.3 Breckenridge Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Breckenridge Pharmaceutical Meloxicam Drug Product Portfolio
6.6.5 Breckenridge Pharmaceutical Recent Developments/Updates
6.7 Zydus Pharmaceuticals
6.7.1 Zydus Pharmaceuticals Company Information
6.7.2 Zydus Pharmaceuticals Description and Business Overview
6.7.3 Zydus Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Zydus Pharmaceuticals Meloxicam Drug Product Portfolio
6.7.5 Zydus Pharmaceuticals Recent Developments/Updates
6.8 Unichem Pharmaceuticals
6.8.1 Unichem Pharmaceuticals Company Information
6.8.2 Unichem Pharmaceuticals Description and Business Overview
6.8.3 Unichem Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Unichem Pharmaceuticals Meloxicam Drug Product Portfolio
6.8.5 Unichem Pharmaceuticals Recent Developments/Updates
6.9 Strides Pharma
6.9.1 Strides Pharma Company Information
6.9.2 Strides Pharma Description and Business Overview
6.9.3 Strides Pharma Meloxicam Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Strides Pharma Meloxicam Drug Product Portfolio
6.9.5 Strides Pharma Recent Developments/Updates
6.10 Cipla
6.10.1 Cipla Company Information
6.10.2 Cipla Description and Business Overview
6.10.3 Cipla Meloxicam Drug Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Cipla Meloxicam Drug Product Portfolio
6.10.5 Cipla Recent Developments/Updates
6.11 Dr. Reddy's Laboratories
6.11.1 Dr. Reddy's Laboratories Company Information
6.11.2 Dr. Reddy's Laboratories Description and Business Overview
6.11.3 Dr. Reddy's Laboratories Meloxicam Drug Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Dr. Reddy's Laboratories Meloxicam Drug Product Portfolio
6.11.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.12 Glenmark Pharmaceuticals
6.12.1 Glenmark Pharmaceuticals Company Information
6.12.2 Glenmark Pharmaceuticals Description and Business Overview
6.12.3 Glenmark Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Glenmark Pharmaceuticals Meloxicam Drug Product Portfolio
6.12.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.13 Teva
6.13.1 Teva Company Information
6.13.2 Teva Description and Business Overview
6.13.3 Teva Meloxicam Drug Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Teva Meloxicam Drug Product Portfolio
6.13.5 Teva Recent Developments/Updates
6.14 PuraCap Pharmaceutical
6.14.1 PuraCap Pharmaceutical Company Information
6.14.2 PuraCap Pharmaceutical Description and Business Overview
6.14.3 PuraCap Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2020-2025)
6.14.4 PuraCap Pharmaceutical Meloxicam Drug Product Portfolio
6.14.5 PuraCap Pharmaceutical Recent Developments/Updates
6.15 TARO
6.15.1 TARO Company Information
6.15.2 TARO Description and Business Overview
6.15.3 TARO Meloxicam Drug Sales, Revenue and Gross Margin (2020-2025)
6.15.4 TARO Meloxicam Drug Product Portfolio
6.15.5 TARO Recent Developments/Updates
6.16 Lupin Pharmaceuticals
6.16.1 Lupin Pharmaceuticals Company Information
6.16.2 Lupin Pharmaceuticals Description and Business Overview
6.16.3 Lupin Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Lupin Pharmaceuticals Meloxicam Drug Product Portfolio
6.16.5 Lupin Pharmaceuticals Recent Developments/Updates
6.17 Aurobindo Pharma
6.17.1 Aurobindo Pharma Company Information
6.17.2 Aurobindo Pharma Description and Business Overview
6.17.3 Aurobindo Pharma Meloxicam Drug Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Aurobindo Pharma Meloxicam Drug Product Portfolio
6.17.5 Aurobindo Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meloxicam Drug Industry Chain Analysis
7.2 Meloxicam Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meloxicam Drug Production Mode & Process Analysis
7.4 Meloxicam Drug Sales and Marketing
7.4.1 Meloxicam Drug Sales Channels
7.4.2 Meloxicam Drug Distributors
7.5 Meloxicam Drug Customer Analysis
8 Meloxicam Drug Market Dynamics
8.1 Meloxicam Drug Industry Trends
8.2 Meloxicam Drug Market Drivers
8.3 Meloxicam Drug Market Challenges
8.4 Meloxicam Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Meloxicam Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Meloxicam Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Meloxicam Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Meloxicam Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Meloxicam Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Meloxicam Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Meloxicam Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Meloxicam Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Meloxicam Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Meloxicam Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Meloxicam Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Meloxicam Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Meloxicam Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meloxicam Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Meloxicam Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Meloxicam Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global Meloxicam Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Meloxicam Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global Meloxicam Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Meloxicam Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Meloxicam Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Meloxicam Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Meloxicam Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Meloxicam Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Meloxicam Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America Meloxicam Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America Meloxicam Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Meloxicam Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Meloxicam Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Meloxicam Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Meloxicam Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Meloxicam Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Meloxicam Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Meloxicam Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Meloxicam Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Meloxicam Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Meloxicam Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Meloxicam Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Meloxicam Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Meloxicam Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Meloxicam Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Meloxicam Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Meloxicam Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Meloxicam Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Meloxicam Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Meloxicam Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Meloxicam Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Meloxicam Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Meloxicam Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global Meloxicam Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global Meloxicam Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Meloxicam Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Meloxicam Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Meloxicam Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Meloxicam Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Meloxicam Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Meloxicam Drug Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Meloxicam Drug Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Meloxicam Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global Meloxicam Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global Meloxicam Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Meloxicam Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Meloxicam Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Meloxicam Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Meloxicam Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Meloxicam Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Meloxicam Drug Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Meloxicam Drug Price (USD/Unit) by Application (2026-2031)
 Table 70. Boehringer-Ingelheim Company Information
 Table 71. Boehringer-Ingelheim Description and Business Overview
 Table 72. Boehringer-Ingelheim Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Boehringer-Ingelheim Meloxicam Drug Product
 Table 74. Boehringer-Ingelheim Recent Developments/Updates
 Table 75. TerSera Therapeutics Company Information
 Table 76. TerSera Therapeutics Description and Business Overview
 Table 77. TerSera Therapeutics Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. TerSera Therapeutics Meloxicam Drug Product
 Table 79. TerSera Therapeutics Recent Developments/Updates
 Table 80. Iroko Pharmaceuticals Company Information
 Table 81. Iroko Pharmaceuticals Description and Business Overview
 Table 82. Iroko Pharmaceuticals Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Iroko Pharmaceuticals Meloxicam Drug Product
 Table 84. Iroko Pharmaceuticals Recent Developments/Updates
 Table 85. Apotex Company Information
 Table 86. Apotex Description and Business Overview
 Table 87. Apotex Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Apotex Meloxicam Drug Product
 Table 89. Apotex Recent Developments/Updates
 Table 90. Yung Shin Pharmaceutical Company Information
 Table 91. Yung Shin Pharmaceutical Description and Business Overview
 Table 92. Yung Shin Pharmaceutical Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Yung Shin Pharmaceutical Meloxicam Drug Product
 Table 94. Yung Shin Pharmaceutical Recent Developments/Updates
 Table 95. Breckenridge Pharmaceutical Company Information
 Table 96. Breckenridge Pharmaceutical Description and Business Overview
 Table 97. Breckenridge Pharmaceutical Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Breckenridge Pharmaceutical Meloxicam Drug Product
 Table 99. Breckenridge Pharmaceutical Recent Developments/Updates
 Table 100. Zydus Pharmaceuticals Company Information
 Table 101. Zydus Pharmaceuticals Description and Business Overview
 Table 102. Zydus Pharmaceuticals Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Zydus Pharmaceuticals Meloxicam Drug Product
 Table 104. Zydus Pharmaceuticals Recent Developments/Updates
 Table 105. Unichem Pharmaceuticals Company Information
 Table 106. Unichem Pharmaceuticals Description and Business Overview
 Table 107. Unichem Pharmaceuticals Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Unichem Pharmaceuticals Meloxicam Drug Product
 Table 109. Unichem Pharmaceuticals Recent Developments/Updates
 Table 110. Strides Pharma Company Information
 Table 111. Strides Pharma Description and Business Overview
 Table 112. Strides Pharma Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Strides Pharma Meloxicam Drug Product
 Table 114. Strides Pharma Recent Developments/Updates
 Table 115. Cipla Company Information
 Table 116. Cipla Description and Business Overview
 Table 117. Cipla Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Cipla Meloxicam Drug Product
 Table 119. Cipla Recent Developments/Updates
 Table 120. Dr. Reddy's Laboratories Company Information
 Table 121. Dr. Reddy's Laboratories Description and Business Overview
 Table 122. Dr. Reddy's Laboratories Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Dr. Reddy's Laboratories Meloxicam Drug Product
 Table 124. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 125. Glenmark Pharmaceuticals Company Information
 Table 126. Glenmark Pharmaceuticals Description and Business Overview
 Table 127. Glenmark Pharmaceuticals Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Glenmark Pharmaceuticals Meloxicam Drug Product
 Table 129. Glenmark Pharmaceuticals Recent Developments/Updates
 Table 130. Teva Company Information
 Table 131. Teva Description and Business Overview
 Table 132. Teva Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Teva Meloxicam Drug Product
 Table 134. Teva Recent Developments/Updates
 Table 135. PuraCap Pharmaceutical Company Information
 Table 136. PuraCap Pharmaceutical Description and Business Overview
 Table 137. PuraCap Pharmaceutical Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. PuraCap Pharmaceutical Meloxicam Drug Product
 Table 139. PuraCap Pharmaceutical Recent Developments/Updates
 Table 140. TARO Company Information
 Table 141. TARO Description and Business Overview
 Table 142. TARO Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 143. TARO Meloxicam Drug Product
 Table 144. TARO Recent Developments/Updates
 Table 145. Lupin Pharmaceuticals Company Information
 Table 146. Lupin Pharmaceuticals Description and Business Overview
 Table 147. Lupin Pharmaceuticals Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 148. Lupin Pharmaceuticals Meloxicam Drug Product
 Table 149. Lupin Pharmaceuticals Recent Developments/Updates
 Table 150. Aurobindo Pharma Company Information
 Table 151. Aurobindo Pharma Description and Business Overview
 Table 152. Aurobindo Pharma Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 153. Aurobindo Pharma Meloxicam Drug Product
 Table 154. Aurobindo Pharma Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Meloxicam Drug Distributors List
 Table 158. Meloxicam Drug Customers List
 Table 159. Meloxicam Drug Market Trends
 Table 160. Meloxicam Drug Market Drivers
 Table 161. Meloxicam Drug Market Challenges
 Table 162. Meloxicam Drug Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Meloxicam Drug
 Figure 2. Global Meloxicam Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Meloxicam Drug Market Share by Type: 2024 & 2031
 Figure 4. Tablet Product Picture
 Figure 5. Capsule Product Picture
 Figure 6. Global Meloxicam Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Meloxicam Drug Market Share by Application: 2024 & 2031
 Figure 8. Osteoarthritis in Adults (OA)
 Figure 9. Rheumatoid Arthritis in Adults (RA)
 Figure 10. Pediatric Patients
 Figure 11. Global Meloxicam Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Meloxicam Drug Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Meloxicam Drug Sales (2020-2031) & (K Units)
 Figure 14. Global Meloxicam Drug Average Price (USD/Unit) & (2020-2031)
 Figure 15. Meloxicam Drug Report Years Considered
 Figure 16. Meloxicam Drug Sales Share by Manufacturers in 2024
 Figure 17. Global Meloxicam Drug Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Meloxicam Drug Players: Market Share by Revenue in Meloxicam Drug in 2024
 Figure 19. Meloxicam Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Meloxicam Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Meloxicam Drug Sales Market Share by Country (2020-2031)
 Figure 22. North America Meloxicam Drug Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Meloxicam Drug Sales Market Share by Country (2020-2031)
 Figure 26. Europe Meloxicam Drug Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Meloxicam Drug Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Meloxicam Drug Revenue Market Share by Region (2020-2031)
 Figure 34. China Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Meloxicam Drug Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Meloxicam Drug Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Meloxicam Drug Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Meloxicam Drug Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Meloxicam Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Meloxicam Drug by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Meloxicam Drug by Type (2020-2031)
 Figure 56. Global Meloxicam Drug Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Meloxicam Drug by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Meloxicam Drug by Application (2020-2031)
 Figure 59. Global Meloxicam Drug Price (USD/Unit) by Application (2020-2031)
 Figure 60. Meloxicam Drug Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS